Protecting Products To Save Lives: Securing The Pharma Supply Chain

Over the past decade the world market for pharmaceuticals has nearly doubled, reaching a total value of approximately $1 trillion. While the industry will continue to develop, its days of consistent high growth appear to be over – a casualty of multiple factors, including healthcare spending cost control efforts, the demise of the ‘blockbuster’ drug and the rise of generics.

A new set of issues is quickly rising to the top of the list of concerns for manufacturers – and they have significant and very direct implications for supply chains. The issues derive from the increasingly complex requirements for securing and protecting product in the supply chain, both in stable developed and rapidly growing emerging markets.